Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse

Fig. 3

Kaplan-Meier plots of the risk of immunoglobulin G4-related disease (IgG4-RD) relapse in patients showing memory B-cell increase or decrease after 6 months of glucocorticoid therapy in absolute counts (a) and as percentage of CD19+ B lymphocytes (b). Two-year time course of naive B cells, memory B cells, circulating plasmablasts, and immunoglobulin G4-related disease responder index (IgG4-RD RI) in relapsing (c) and nonrelapsing (d) patients with IgG4-RD. Arrows indicate IgG4-RD flares. Results are presented as mean ± SEM

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us